1932

Abstract

Insulin-like signaling is critical for nutrient homeostasis, growth and survival. However, work with lower metazoans— and —shows that reduced insulin-like signaling extends life span. In addition, reduced insulin signaling in higher animals—rodents and humans—causes glucose intolerance and hyperinsulinemia that progresses to diabetes and shortens the life span of affected individuals. Hyperinsulinemia usually develops to maintain glucose homeostasis and prevent the progression toward life-threatening type 2 diabetes; however, increased circulating insulin may have negative effects on the brain that promote age-related disease. We discuss the possibility that the brain is the site where reduced insulin-like signaling can consistently extend mammalian life span—just as reduced insulin-like signaling extends the life span of lower metazoans.

Loading

Article metrics loading...

/content/journals/10.1146/annurev.physiol.70.113006.100533
2008-03-17
2024-03-29
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.physiol.70.113006.100533
Loading
/content/journals/10.1146/annurev.physiol.70.113006.100533
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error